<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DrugDDI.d409" origId="Desipramine"><sentence id="DrugDDI.d409.s0" origId="s0" text="1."/><sentence id="DrugDDI.d409.s1" origId="s1" text="Drugs Metabolized by P450 2D6: The biochemical activity of the drug metabolizing isozyme cytochrome P450 2D6 (debrisoquin hydroxylase) is reduced in a subset of the caucasian population (about 7 to 10% of caucasians are so called poor metabolizers);"><entity charOffset="0-5" id="DrugDDI.d409.s1.e0" origId="s1.p1" text="Drugs" type="drug"/><entity charOffset="21-30" id="DrugDDI.d409.s1.e1" origId="s1.p3" text="P450 2D6" type="drug"/><entity charOffset="63-67" id="DrugDDI.d409.s1.e2" origId="s1.p6" text="drug" type="drug"/><entity charOffset="110-134" id="DrugDDI.d409.s1.e3" origId="s1.p8" text="debrisoquin hydroxylase" type="drug"/><pair e1="DrugDDI.d409.s1.e0" e2="DrugDDI.d409.s1.e1" id="DrugDDI.d409.s1.p0" interaction="false"/><pair e1="DrugDDI.d409.s1.e0" e2="DrugDDI.d409.s1.e2" id="DrugDDI.d409.s1.p1" interaction="false"/><pair e1="DrugDDI.d409.s1.e0" e2="DrugDDI.d409.s1.e3" id="DrugDDI.d409.s1.p2" interaction="false"/><pair e1="DrugDDI.d409.s1.e1" e2="DrugDDI.d409.s1.e2" id="DrugDDI.d409.s1.p3" interaction="false"/><pair e1="DrugDDI.d409.s1.e1" e2="DrugDDI.d409.s1.e3" id="DrugDDI.d409.s1.p4" interaction="false"/><pair e1="DrugDDI.d409.s1.e2" e2="DrugDDI.d409.s1.e3" id="DrugDDI.d409.s1.p5" interaction="false"/></sentence><sentence id="DrugDDI.d409.s2" origId="s2" text="reliable estimates of the prevalence of reduced P450 2D6 isozyme activity among Asian, African and other populations are not yet available."><entity charOffset="48-65" id="DrugDDI.d409.s2.e0" origId="s2.p26" text="P450 2D6 isozyme" type="drug"/><negationtags>reliable estimates of the prevalence of reduced P450 2D6 isozyme activity among Asian, African and other populations are &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; yet available&lt;/xcope&gt;.</negationtags><negationtags>reliable estimates of the prevalence of reduced P450 2D6 isozyme activity among Asian, African and other populations are &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; yet available&lt;/xcope&gt;.</negationtags><negationtags>reliable estimates of the prevalence of reduced P450 2D6 isozyme activity among Asian, African and other populations are &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; yet available&lt;/xcope&gt;.</negationtags><negationtags>reliable estimates of the prevalence of reduced P450 2D6 isozyme activity among Asian, African and other populations are &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; yet available&lt;/xcope&gt;.</negationtags><negationtags>reliable estimates of the prevalence of reduced P450 2D6 isozyme activity among Asian, African and other populations are &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; yet available&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d409.s3" origId="s3" text="Poor metabolizers have higher than expected plasma concentrations of tricyclic antidepressants (TCAs) when given usual doses."><entity charOffset="69-94" id="DrugDDI.d409.s3.e0" origId="s3.p37" text="tricyclic antidepressants" type="drug"/></sentence><sentence id="DrugDDI.d409.s4" origId="s4" text="Depending on the traction of drug metabolized by P450 2D6, the increase in plasma concentration may be small, or quite large (8 fold increase in plasma AUC of the TCA)."><entity charOffset="29-33" id="DrugDDI.d409.s4.e0" origId="s4.p45" text="drug" type="drug"/><entity charOffset="49-58" id="DrugDDI.d409.s4.e1" origId="s4.p47" text="P450 2D6" type="drug"/><pair e1="DrugDDI.d409.s4.e0" e2="DrugDDI.d409.s4.e1" id="DrugDDI.d409.s4.p0" interaction="false"/></sentence><sentence id="DrugDDI.d409.s5" origId="s5" text="In addition, certain drugs inhibit the activity of this isozyme and make normal metabolizers resemble p.o."><entity charOffset="21-26" id="DrugDDI.d409.s5.e0" origId="s5.p61" text="drugs" type="drug"/><entity charOffset="56-63" id="DrugDDI.d409.s5.e1" origId="s5.p64" text="isozyme" type="drug"/><pair e1="DrugDDI.d409.s5.e0" e2="DrugDDI.d409.s5.e1" id="DrugDDI.d409.s5.p0" interaction="false"/></sentence><sentence id="DrugDDI.d409.s6" origId="s6" text="metabolizers."/><sentence id="DrugDDI.d409.s7" origId="s7" text="An individual who is stable on a given dose of TCA may become abruptly toxic when given one of these inhibiting drugs as concomitant therapy."><entity charOffset="112-117" id="DrugDDI.d409.s7.e0" origId="s7.p82" text="drugs" type="drug"/></sentence><sentence id="DrugDDI.d409.s8" origId="s8" text="The drugs that inhibit cytochrome P450 2D6 include some that are not metabolized by the enzyme (quinidine;"><entity charOffset="4-9" id="DrugDDI.d409.s8.e0" origId="s8.p84" text="drugs" type="drug"/><entity charOffset="23-42" id="DrugDDI.d409.s8.e1" origId="s8.p87" text="cytochrome P450 2D6" type="drug"/><entity charOffset="96-105" id="DrugDDI.d409.s8.e2" origId="s8.p96" text="quinidine" type="drug"/><pair e1="DrugDDI.d409.s8.e0" e2="DrugDDI.d409.s8.e1" id="DrugDDI.d409.s8.p0" interaction="false"/><pair e1="DrugDDI.d409.s8.e0" e2="DrugDDI.d409.s8.e2" id="DrugDDI.d409.s8.p1" interaction="false"/><pair e1="DrugDDI.d409.s8.e1" e2="DrugDDI.d409.s8.e2" id="DrugDDI.d409.s8.p2" interaction="false"/><negationtags>&lt;xcope&gt;The drugs that inhibit cytochrome P450 2D6 include some that are &lt;cue&gt;not&lt;/cue&gt; metabolized by the enzyme (quinidine&lt;/xcope&gt;;</negationtags><negationtags>&lt;xcope&gt;The drugs that inhibit cytochrome P450 2D6 include some that are &lt;cue&gt;not&lt;/cue&gt; metabolized by the enzyme (quinidine;&lt;/xcope&gt;</negationtags><negationtags>The drugs that inhibit cytochrome P450 2D6 include some that are &lt;xcope&gt;not metabolized by the enzyme (quinidine;</negationtags><negationtags>&lt;xcope&gt;The drugs that inhibit cytochrome P450 2D6 include some that are &lt;cue&gt;not&lt;/cue&gt; metabolized &lt;/xcope&gt;by the enzyme (quinidine;</negationtags><negationtags>&lt;xcope&gt; The drugs that inhibit cytochrome P450 2D6 include some that are &lt;cue&gt;not&lt;/cue&gt; metabolized &lt;/xcope&gt;by the enzyme (quinidine;</negationtags></sentence><sentence id="DrugDDI.d409.s9" origId="s9" text="cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythrnics propatenone and flecainide)."><entity charOffset="0-10" id="DrugDDI.d409.s9.e0" origId="s9.p98" text="cimetidine" type="drug"/><entity charOffset="45-54" id="DrugDDI.d409.s9.e1" origId="s9.p105" text="P450 2D6" type="drug"/><entity charOffset="66-81" id="DrugDDI.d409.s9.e2" origId="s9.p107" text="antidepressants" type="drug"/><entity charOffset="83-97" id="DrugDDI.d409.s9.e3" origId="s9.p108" text="phenothiazines" type="drug"/><entity charOffset="148-158" id="DrugDDI.d409.s9.e4" origId="s9.p112" text="flecainide" type="drug"/><pair e1="DrugDDI.d409.s9.e0" e2="DrugDDI.d409.s9.e1" id="DrugDDI.d409.s9.p0" interaction="false"/><pair e1="DrugDDI.d409.s9.e0" e2="DrugDDI.d409.s9.e2" id="DrugDDI.d409.s9.p1" interaction="false"/><pair e1="DrugDDI.d409.s9.e0" e2="DrugDDI.d409.s9.e3" id="DrugDDI.d409.s9.p2" interaction="false"/><pair e1="DrugDDI.d409.s9.e0" e2="DrugDDI.d409.s9.e4" id="DrugDDI.d409.s9.p3" interaction="false"/><pair e1="DrugDDI.d409.s9.e1" e2="DrugDDI.d409.s9.e2" id="DrugDDI.d409.s9.p4" interaction="false"/><pair e1="DrugDDI.d409.s9.e1" e2="DrugDDI.d409.s9.e3" id="DrugDDI.d409.s9.p5" interaction="false"/><pair e1="DrugDDI.d409.s9.e1" e2="DrugDDI.d409.s9.e4" id="DrugDDI.d409.s9.p6" interaction="false"/><pair e1="DrugDDI.d409.s9.e2" e2="DrugDDI.d409.s9.e3" id="DrugDDI.d409.s9.p7" interaction="false"/><pair e1="DrugDDI.d409.s9.e2" e2="DrugDDI.d409.s9.e4" id="DrugDDI.d409.s9.p8" interaction="false"/><pair e1="DrugDDI.d409.s9.e3" e2="DrugDDI.d409.s9.e4" id="DrugDDI.d409.s9.p9" interaction="false"/></sentence><sentence id="DrugDDI.d409.s10" origId="s10" text="While all the selective serotonin reuptake inhibitors (SSRIs), e.g., fluoxetine, seriraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition."><entity charOffset="24-53" id="DrugDDI.d409.s10.e0" origId="s10.p116" text="serotonin reuptake inhibitors" type="drug"/><entity charOffset="69-79" id="DrugDDI.d409.s10.e1" origId="s10.p123" text="fluoxetine" type="drug"/><entity charOffset="97-107" id="DrugDDI.d409.s10.e2" origId="s10.p126" text="paroxetine" type="drug"/><entity charOffset="117-126" id="DrugDDI.d409.s10.e3" origId="s10.p128" text="P450 2D6" type="drug"/><pair e1="DrugDDI.d409.s10.e0" e2="DrugDDI.d409.s10.e1" id="DrugDDI.d409.s10.p0" interaction="false"/><pair e1="DrugDDI.d409.s10.e0" e2="DrugDDI.d409.s10.e2" id="DrugDDI.d409.s10.p1" interaction="false"/><pair e1="DrugDDI.d409.s10.e0" e2="DrugDDI.d409.s10.e3" id="DrugDDI.d409.s10.p2" interaction="false"/><pair e1="DrugDDI.d409.s10.e1" e2="DrugDDI.d409.s10.e2" id="DrugDDI.d409.s10.p3" interaction="false"/><pair e1="DrugDDI.d409.s10.e1" e2="DrugDDI.d409.s10.e3" id="DrugDDI.d409.s10.p4" interaction="false"/><pair e1="DrugDDI.d409.s10.e2" e2="DrugDDI.d409.s10.e3" id="DrugDDI.d409.s10.p5" interaction="false"/></sentence><sentence id="DrugDDI.d409.s11" origId="s11" text="The extent to which SSRI-TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved."/><sentence id="DrugDDI.d409.s12" origId="s12" text="Nevertheless, caution is indicated in the co-administration of T.A. with any of the SSRIs and also in switching from one class to the other."><entity charOffset="63-65" id="DrugDDI.d409.s12.e0" origId="s12.p152" text="T" type="drug"/></sentence><sentence id="DrugDDI.d409.s13" origId="s13" text="Of particular importance, sufficient time must elapse before initiating TCA treatment in a patient being withdrawn from fluoxetine, given the long half-life of the parent and active metabolite (at least 5 weeks may be necessary)."><entity charOffset="120-130" id="DrugDDI.d409.s13.e0" origId="s13.p169" text="fluoxetine" type="drug"/><entity charOffset="175-192" id="DrugDDI.d409.s13.e1" origId="s13.p174" text="active metabolite" type="drug"/><pair e1="DrugDDI.d409.s13.e0" e2="DrugDDI.d409.s13.e1" id="DrugDDI.d409.s13.p0" interaction="false"/></sentence><sentence id="DrugDDI.d409.s14" origId="s14" text="Concomitant use of tricyclic antidepressants with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant or the other drug."><entity charOffset="19-44" id="DrugDDI.d409.s14.e0" origId="s14.p182" text="tricyclic antidepressants" type="drug"/><entity charOffset="50-55" id="DrugDDI.d409.s14.e1" origId="s14.p183" text="drugs" type="drug"/><entity charOffset="73-92" id="DrugDDI.d409.s14.e2" origId="s14.p187" text="cytochrome P450 2D6" type="drug"/><entity charOffset="156-180" id="DrugDDI.d409.s14.e3" origId="s14.p195" text="tricyclic antidepressant" type="drug"/><entity charOffset="194-198" id="DrugDDI.d409.s14.e4" origId="s14.p197" text="drug" type="drug"/><pair e1="DrugDDI.d409.s14.e0" e2="DrugDDI.d409.s14.e1" id="DrugDDI.d409.s14.p0" interaction="true"/><pair e1="DrugDDI.d409.s14.e0" e2="DrugDDI.d409.s14.e2" id="DrugDDI.d409.s14.p1" interaction="false"/><pair e1="DrugDDI.d409.s14.e0" e2="DrugDDI.d409.s14.e3" id="DrugDDI.d409.s14.p2" interaction="false"/><pair e1="DrugDDI.d409.s14.e0" e2="DrugDDI.d409.s14.e4" id="DrugDDI.d409.s14.p3" interaction="false"/><pair e1="DrugDDI.d409.s14.e1" e2="DrugDDI.d409.s14.e2" id="DrugDDI.d409.s14.p4" interaction="false"/><pair e1="DrugDDI.d409.s14.e1" e2="DrugDDI.d409.s14.e3" id="DrugDDI.d409.s14.p5" interaction="false"/><pair e1="DrugDDI.d409.s14.e1" e2="DrugDDI.d409.s14.e4" id="DrugDDI.d409.s14.p6" interaction="false"/><pair e1="DrugDDI.d409.s14.e2" e2="DrugDDI.d409.s14.e3" id="DrugDDI.d409.s14.p7" interaction="false"/><pair e1="DrugDDI.d409.s14.e2" e2="DrugDDI.d409.s14.e4" id="DrugDDI.d409.s14.p8" interaction="false"/><pair e1="DrugDDI.d409.s14.e3" e2="DrugDDI.d409.s14.e4" id="DrugDDI.d409.s14.p9" interaction="false"/></sentence><sentence id="DrugDDI.d409.s15" origId="s15" text="Furthermore, whenever one of these other drugs is withdrawn from co-therapy, an increased dose of tricyclic antidepressant may be required."><entity charOffset="41-46" id="DrugDDI.d409.s15.e0" origId="s15.p201" text="drugs" type="drug"/><entity charOffset="98-122" id="DrugDDI.d409.s15.e1" origId="s15.p206" text="tricyclic antidepressant" type="drug"/><pair e1="DrugDDI.d409.s15.e0" e2="DrugDDI.d409.s15.e1" id="DrugDDI.d409.s15.p0" interaction="false"/></sentence><sentence id="DrugDDI.d409.s16" origId="s16" text="It is desirable to monitor TCA plasma levels whenever a TCA is going to be co-administered with another drug known to be an inhibitor of P450 2D6."><entity charOffset="104-108" id="DrugDDI.d409.s16.e0" origId="s16.p222" text="drug" type="drug"/><entity charOffset="137-146" id="DrugDDI.d409.s16.e1" origId="s16.p227" text="P450 2D6" type="drug"/><pair e1="DrugDDI.d409.s16.e0" e2="DrugDDI.d409.s16.e1" id="DrugDDI.d409.s16.p0" interaction="false"/></sentence><sentence id="DrugDDI.d409.s17" origId="s17" text="2."/><sentence id="DrugDDI.d409.s18" origId="s18" text="Close supervision and careful adjustment of dosage are required when this drug is given concomitantly with anticholinergic or sympathomimetic drugs."><entity charOffset="74-78" id="DrugDDI.d409.s18.e0" origId="s18.p236" text="drug" type="drug"/><entity charOffset="107-122" id="DrugDDI.d409.s18.e1" origId="s18.p240" text="anticholinergic" type="drug"/><entity charOffset="126-147" id="DrugDDI.d409.s18.e2" origId="s18.p242" text="sympathomimetic drugs" type="drug"/><pair e1="DrugDDI.d409.s18.e0" e2="DrugDDI.d409.s18.e1" id="DrugDDI.d409.s18.p0" interaction="true"/><pair e1="DrugDDI.d409.s18.e0" e2="DrugDDI.d409.s18.e2" id="DrugDDI.d409.s18.p1" interaction="true"/><pair e1="DrugDDI.d409.s18.e1" e2="DrugDDI.d409.s18.e2" id="DrugDDI.d409.s18.p2" interaction="false"/></sentence><sentence id="DrugDDI.d409.s19" origId="s19" text="3."/><sentence id="DrugDDI.d409.s20" origId="s20" text="Clinical experience in the concurrent administration of ECT and antidepressant drugs is limited."><entity charOffset="64-84" id="DrugDDI.d409.s20.e0" origId="s20.p248" text="antidepressant drugs" type="drug"/></sentence><sentence id="DrugDDI.d409.s21" origId="s21" text="Thus, if such treatment is essential, the possibility of increased risk relative to benefits should be considered."/><sentence id="DrugDDI.d409.s22" origId="s22" text="4."/><sentence id="DrugDDI.d409.s23" origId="s23" text="If desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive."><entity charOffset="3-28" id="DrugDDI.d409.s23.e0" origId="s23.p263" text="desipramine hydrochloride" type="drug"/><entity charOffset="58-77" id="DrugDDI.d409.s23.e1" origId="s23.p268" text="psychotropic agents" type="drug"/><entity charOffset="86-99" id="DrugDDI.d409.s23.e2" origId="s23.p269" text="tranquilizers" type="drug"/><entity charOffset="103-111" id="DrugDDI.d409.s23.e3" origId="s23.p271" text="sedative" type="drug"/><entity charOffset="112-121" id="DrugDDI.d409.s23.e4" origId="s23.p272" text="hypnotics" type="drug"/><entity charOffset="214-222" id="DrugDDI.d409.s23.e5" origId="s23.p281" text="sedative" type="drug"/><entity charOffset="234-245" id="DrugDDI.d409.s23.e6" origId="s23.p282" text="desipramine" type="drug"/><entity charOffset="250-265" id="DrugDDI.d409.s23.e7" origId="s23.p284" text="benzodiazepines" type="drug"/><entity charOffset="273-289" id="DrugDDI.d409.s23.e8" origId="s23.p287" text="chlordiazepoxide" type="drug"/><entity charOffset="293-301" id="DrugDDI.d409.s23.e9" origId="s23.p289" text="diazepam" type="drug"/><pair e1="DrugDDI.d409.s23.e0" e2="DrugDDI.d409.s23.e1" id="DrugDDI.d409.s23.p0" interaction="true"/><pair e1="DrugDDI.d409.s23.e0" e2="DrugDDI.d409.s23.e2" id="DrugDDI.d409.s23.p1" interaction="true"/><pair e1="DrugDDI.d409.s23.e0" e2="DrugDDI.d409.s23.e3" id="DrugDDI.d409.s23.p2" interaction="true"/><pair e1="DrugDDI.d409.s23.e0" e2="DrugDDI.d409.s23.e4" id="DrugDDI.d409.s23.p3" interaction="true"/><pair e1="DrugDDI.d409.s23.e0" e2="DrugDDI.d409.s23.e5" id="DrugDDI.d409.s23.p4" interaction="false"/><pair e1="DrugDDI.d409.s23.e0" e2="DrugDDI.d409.s23.e6" id="DrugDDI.d409.s23.p5" interaction="false"/><pair e1="DrugDDI.d409.s23.e0" e2="DrugDDI.d409.s23.e7" id="DrugDDI.d409.s23.p6" interaction="false"/><pair e1="DrugDDI.d409.s23.e0" e2="DrugDDI.d409.s23.e8" id="DrugDDI.d409.s23.p7" interaction="false"/><pair e1="DrugDDI.d409.s23.e0" e2="DrugDDI.d409.s23.e9" id="DrugDDI.d409.s23.p8" interaction="false"/><pair e1="DrugDDI.d409.s23.e1" e2="DrugDDI.d409.s23.e2" id="DrugDDI.d409.s23.p9" interaction="false"/><pair e1="DrugDDI.d409.s23.e1" e2="DrugDDI.d409.s23.e3" id="DrugDDI.d409.s23.p10" interaction="false"/><pair e1="DrugDDI.d409.s23.e1" e2="DrugDDI.d409.s23.e4" id="DrugDDI.d409.s23.p11" interaction="false"/><pair e1="DrugDDI.d409.s23.e1" e2="DrugDDI.d409.s23.e5" id="DrugDDI.d409.s23.p12" interaction="false"/><pair e1="DrugDDI.d409.s23.e1" e2="DrugDDI.d409.s23.e6" id="DrugDDI.d409.s23.p13" interaction="false"/><pair e1="DrugDDI.d409.s23.e1" e2="DrugDDI.d409.s23.e7" id="DrugDDI.d409.s23.p14" interaction="false"/><pair e1="DrugDDI.d409.s23.e1" e2="DrugDDI.d409.s23.e8" id="DrugDDI.d409.s23.p15" interaction="false"/><pair e1="DrugDDI.d409.s23.e1" e2="DrugDDI.d409.s23.e9" id="DrugDDI.d409.s23.p16" interaction="false"/><pair e1="DrugDDI.d409.s23.e2" e2="DrugDDI.d409.s23.e3" id="DrugDDI.d409.s23.p17" interaction="false"/><pair e1="DrugDDI.d409.s23.e2" e2="DrugDDI.d409.s23.e4" id="DrugDDI.d409.s23.p18" interaction="false"/><pair e1="DrugDDI.d409.s23.e2" e2="DrugDDI.d409.s23.e5" id="DrugDDI.d409.s23.p19" interaction="false"/><pair e1="DrugDDI.d409.s23.e2" e2="DrugDDI.d409.s23.e6" id="DrugDDI.d409.s23.p20" interaction="false"/><pair e1="DrugDDI.d409.s23.e2" e2="DrugDDI.d409.s23.e7" id="DrugDDI.d409.s23.p21" interaction="false"/><pair e1="DrugDDI.d409.s23.e2" e2="DrugDDI.d409.s23.e8" id="DrugDDI.d409.s23.p22" interaction="false"/><pair e1="DrugDDI.d409.s23.e2" e2="DrugDDI.d409.s23.e9" id="DrugDDI.d409.s23.p23" interaction="false"/><pair e1="DrugDDI.d409.s23.e3" e2="DrugDDI.d409.s23.e4" id="DrugDDI.d409.s23.p24" interaction="false"/><pair e1="DrugDDI.d409.s23.e3" e2="DrugDDI.d409.s23.e5" id="DrugDDI.d409.s23.p25" interaction="false"/><pair e1="DrugDDI.d409.s23.e3" e2="DrugDDI.d409.s23.e6" id="DrugDDI.d409.s23.p26" interaction="false"/><pair e1="DrugDDI.d409.s23.e3" e2="DrugDDI.d409.s23.e7" id="DrugDDI.d409.s23.p27" interaction="false"/><pair e1="DrugDDI.d409.s23.e3" e2="DrugDDI.d409.s23.e8" id="DrugDDI.d409.s23.p28" interaction="false"/><pair e1="DrugDDI.d409.s23.e3" e2="DrugDDI.d409.s23.e9" id="DrugDDI.d409.s23.p29" interaction="false"/><pair e1="DrugDDI.d409.s23.e4" e2="DrugDDI.d409.s23.e5" id="DrugDDI.d409.s23.p30" interaction="false"/><pair e1="DrugDDI.d409.s23.e4" e2="DrugDDI.d409.s23.e6" id="DrugDDI.d409.s23.p31" interaction="false"/><pair e1="DrugDDI.d409.s23.e4" e2="DrugDDI.d409.s23.e7" id="DrugDDI.d409.s23.p32" interaction="false"/><pair e1="DrugDDI.d409.s23.e4" e2="DrugDDI.d409.s23.e8" id="DrugDDI.d409.s23.p33" interaction="false"/><pair e1="DrugDDI.d409.s23.e4" e2="DrugDDI.d409.s23.e9" id="DrugDDI.d409.s23.p34" interaction="false"/><pair e1="DrugDDI.d409.s23.e5" e2="DrugDDI.d409.s23.e6" id="DrugDDI.d409.s23.p35" interaction="false"/><pair e1="DrugDDI.d409.s23.e5" e2="DrugDDI.d409.s23.e7" id="DrugDDI.d409.s23.p36" interaction="false"/><pair e1="DrugDDI.d409.s23.e5" e2="DrugDDI.d409.s23.e8" id="DrugDDI.d409.s23.p37" interaction="false"/><pair e1="DrugDDI.d409.s23.e5" e2="DrugDDI.d409.s23.e9" id="DrugDDI.d409.s23.p38" interaction="false"/><pair e1="DrugDDI.d409.s23.e6" e2="DrugDDI.d409.s23.e7" id="DrugDDI.d409.s23.p39" interaction="false"/><pair e1="DrugDDI.d409.s23.e6" e2="DrugDDI.d409.s23.e8" id="DrugDDI.d409.s23.p40" interaction="false"/><pair e1="DrugDDI.d409.s23.e6" e2="DrugDDI.d409.s23.e9" id="DrugDDI.d409.s23.p41" interaction="false"/><pair e1="DrugDDI.d409.s23.e7" e2="DrugDDI.d409.s23.e8" id="DrugDDI.d409.s23.p42" interaction="false"/><pair e1="DrugDDI.d409.s23.e7" e2="DrugDDI.d409.s23.e9" id="DrugDDI.d409.s23.p43" interaction="false"/><pair e1="DrugDDI.d409.s23.e8" e2="DrugDDI.d409.s23.e9" id="DrugDDI.d409.s23.p44" interaction="false"/></sentence><sentence id="DrugDDI.d409.s24" origId="s24" text="Both the sedative and anticholinergic effects of the major tranquilizers are also additive to those of desipramine."><entity charOffset="9-17" id="DrugDDI.d409.s24.e0" origId="s24.p294" text="sedative" type="drug"/><entity charOffset="22-37" id="DrugDDI.d409.s24.e1" origId="s24.p296" text="anticholinergic" type="drug"/><entity charOffset="53-72" id="DrugDDI.d409.s24.e2" origId="s24.p297" text="major tranquilizers" type="drug"/><entity charOffset="103-114" id="DrugDDI.d409.s24.e3" origId="s24.p300" text="desipramine" type="drug"/><pair e1="DrugDDI.d409.s24.e0" e2="DrugDDI.d409.s24.e1" id="DrugDDI.d409.s24.p0" interaction="false"/><pair e1="DrugDDI.d409.s24.e0" e2="DrugDDI.d409.s24.e2" id="DrugDDI.d409.s24.p1" interaction="false"/><pair e1="DrugDDI.d409.s24.e0" e2="DrugDDI.d409.s24.e3" id="DrugDDI.d409.s24.p2" interaction="false"/><pair e1="DrugDDI.d409.s24.e1" e2="DrugDDI.d409.s24.e2" id="DrugDDI.d409.s24.p3" interaction="false"/><pair e1="DrugDDI.d409.s24.e1" e2="DrugDDI.d409.s24.e3" id="DrugDDI.d409.s24.p4" interaction="false"/><pair e1="DrugDDI.d409.s24.e2" e2="DrugDDI.d409.s24.e3" id="DrugDDI.d409.s24.p5" interaction="false"/></sentence><sentence id="DrugDDI.d409.s25" origId="s25" text="5."/><sentence id="DrugDDI.d409.s26" origId="s26" text="Concurrent administration of cimetidine and tricyclic antidepressants can produce clinically significant increases in the plasma levels of the tricyclic antidepressants."><entity charOffset="29-39" id="DrugDDI.d409.s26.e0" origId="s26.p303" text="cimetidine" type="drug"/><entity charOffset="44-69" id="DrugDDI.d409.s26.e1" origId="s26.p305" text="tricyclic antidepressants" type="drug"/><entity charOffset="143-168" id="DrugDDI.d409.s26.e2" origId="s26.p310" text="tricyclic antidepressants" type="drug"/><pair e1="DrugDDI.d409.s26.e0" e2="DrugDDI.d409.s26.e1" id="DrugDDI.d409.s26.p0" interaction="true"/><pair e1="DrugDDI.d409.s26.e0" e2="DrugDDI.d409.s26.e2" id="DrugDDI.d409.s26.p1" interaction="false"/><pair e1="DrugDDI.d409.s26.e1" e2="DrugDDI.d409.s26.e2" id="DrugDDI.d409.s26.p2" interaction="false"/></sentence><sentence id="DrugDDI.d409.s27" origId="s27" text="Conversely, decreases in plasma levels of the tricyclic antidepressants have been reported upon discontinuation of cimetidine which may result in the loss of the therapeutic efficacy of the tricyclic antidepressant 6."><entity charOffset="46-71" id="DrugDDI.d409.s27.e0" origId="s27.p314" text="tricyclic antidepressants" type="drug"/><entity charOffset="115-125" id="DrugDDI.d409.s27.e1" origId="s27.p319" text="cimetidine" type="drug"/><entity charOffset="190-214" id="DrugDDI.d409.s27.e2" origId="s27.p325" text="tricyclic antidepressant" type="drug"/><pair e1="DrugDDI.d409.s27.e0" e2="DrugDDI.d409.s27.e1" id="DrugDDI.d409.s27.p0" interaction="true"/><pair e1="DrugDDI.d409.s27.e0" e2="DrugDDI.d409.s27.e2" id="DrugDDI.d409.s27.p1" interaction="false"/><pair e1="DrugDDI.d409.s27.e1" e2="DrugDDI.d409.s27.e2" id="DrugDDI.d409.s27.p2" interaction="false"/></sentence><sentence id="DrugDDI.d409.s28" origId="s28" text="There have been greater than two-fold increases of previously stable plasma levels of tricyclic antidepressants when fluoxetine has been administered in combination with these agents."><entity charOffset="86-111" id="DrugDDI.d409.s28.e0" origId="s28.p333" text="tricyclic antidepressants" type="drug"/><entity charOffset="117-127" id="DrugDDI.d409.s28.e1" origId="s28.p335" text="fluoxetine" type="drug"/><pair e1="DrugDDI.d409.s28.e0" e2="DrugDDI.d409.s28.e1" id="DrugDDI.d409.s28.p0" interaction="true"/></sentence></document>